35
Participants
Start Date
October 31, 1999
Primary Completion Date
October 31, 2002
Study Completion Date
March 31, 2007
filgrastim
asparaginase
cytarabine
daunorubicin hydrochloride
melphalan
thioguanine
peripheral blood stem cell transplantation
Mount Sinai School of Medicine, New York
Johns Hopkins Oncology Center, Baltimore
Emory University Hospital - Atlanta, Atlanta
Nemours Children's Clinic, Jacksonville
University of Alabama Comprehensive Cancer Center, Birmingham
Children's Hospital of Michigan, Detroit
Midwest Children's Cancer Center, Milwaukee
Children's Memorial Hospital, Chicago, Chicago
Cardinal Glennon Children's Hospital, St Louis
University of Arkansas for Medical Sciences, Little Rock
Cook Children's Medical Center - Fort Worth, Fort Worth
Arizona Cancer Center, Tucson
Lucile Packard Children's Hospital at Stanford, Palo Alto
Children's Hospital and Health Center, San Diego
Maine Children's Cancer Program, Scarborough
Massachusetts General Hospital Cancer Center, Boston
Hackensack University Medical Center, Hackensack
Tomorrows Children's Institute, Hackensack
Simmons Cancer Center - Dallas, Dallas
Montreal Children's Hospital, Montreal
National Cancer Institute (NCI)
NIH
Children's Oncology Group
NETWORK